Amgen Inc at JPMorgan Healthcare Conference Transcript
So good afternoon, everybody. I'm Chris Schott from JPMorgan. And it's my pleasure to be introducing Amgen today. From the company, we have Chairman and CEO, Bob Bradway. Bob, Happy New Year, and thanks for joining us today.
Looking forward to the presentation. We're going to do a presentation on stage, and we'll do a breakout to a Q&A session after that. So, over to you, Bob.
Okay. Very good. Thank you, Chris, and good afternoon, everyone. It's wonderful to see you here. A pleasure to kick off 2026 with all of you. And we're excited about 2026 at Amgen.
We see this as a springboard year for us with quite a lot of exciting, in particular clinical data being generated at Amgen in 2026. So let me jump straight in. You're familiar with the elements of our Safe Harbor.
But just briefly, for those of you who perhaps don't know Amgen as well as some others, let me just point out that we are
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
